High Vista Strategies LLC Pharvaris N.V. Transaction History
High Vista Strategies LLC
- $249 Million
- Q2 2024
A detailed history of High Vista Strategies LLC transactions in Pharvaris N.V. stock. As of the latest transaction made, High Vista Strategies LLC holds 16,750 shares of PHVS stock, worth $310,545. This represents 0.13% of its overall portfolio holdings.
Number of Shares
16,750
Previous 16,750
-0.0%
Holding current value
$310,545
Previous $387,000
18.86%
% of portfolio
0.13%
Previous 0.15%
Shares
1 transactions
Others Institutions Holding PHVS
# of Institutions
36Shares Held
37.8MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$140 Million4.48% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.29MShares$79.6 Million54.23% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$79.5 Million45.57% of portfolio
-
Viking Global Investors LP3.65MShares$67.7 Million0.27% of portfolio
-
Vr Adviser, LLC New York, NY3.4MShares$63 Million7.0% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $626M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...